TA
ARRY

Teachers Advisors’s Array Biopharma Inc ARRY Stock Holding History

Teachers Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$17.4M Sell
714,190
-340,694
-32% -$7.09M 0.02% 723
2018
Q4 		$15M Buy
1,054,884
+39,184
+4% +$594K 0.02% 723
2018
Q3 		$15.4M Sell
1,015,700
-445,706
-30% -$6.83M 0.02% 860
2018
Q2 		$24.5M Buy
1,461,406
+18,370
+1% +$292K 0.03% 627
2018
Q1 		$23.6M Buy
1,443,036
+123,412
+9% +$1.98M 0.03% 610
2017
Q4 		$16.9M Buy
1,319,624
+45,401
+4% +$516K 0.02% 813
2017
Q3 		$15.7M Sell
1,274,223
-505
-0% -$4.69K 0.02% 812
2017
Q2 		$10.7M Buy
1,274,728
+434,010
+52% +$3.55M 0.01% 965
2017
Q1 		$7.52M Sell
840,718
-1,199,733
-59% -$12.8M 0.01% 1105
2016
Q4 		$17.9M Buy
2,040,451
+61,659
+3% +$454K 0.03% 687
2016
Q3 		$13.4M Buy
1,978,792
+652
+0% +$2.52K 0.02% 799
2016
Q2 		$7.04M Buy
1,978,140
+63,994
+3% +$209K 0.01% 1033
2016
Q1 		$5.65M Buy
1,914,146
+663,458
+53% +$1.99M 0.01% 1080
2015
Q4 		$5.28M Buy
1,250,688
+1,046,060
+511% +$4.77M 0.01% 1117
2015
Q3 		$933K Hold
204,628
– – ﹤0.01% 2035
2015
Q2 		$1.48M Buy
204,628
+10,118
+5% +$74.7K ﹤0.01% 1886
2015
Q1 		$1.43M Buy
194,510
+16,547
+9% +$118K ﹤0.01% 1862
2014
Q4 		$842K Hold
177,963
– – ﹤0.01% 2133
2014
Q3 		$635K Hold
177,963
– – ﹤0.01% 2259
2014
Q2 		$812K Sell
177,963
-641,619
-78% -$2.65M ﹤0.01% 2159
2014
Q1 		$3.85M Sell
819,582
-238,820
-23% -$1.2M 0.01% 1212
2013
Q4 		$5.3M Buy
1,058,402
+41,780
+4% +$227K 0.01% 1067
2013
Q3 		$6.32M Buy
1,016,622
+6,506
+0.6% +$38.6K 0.02% 952
2013
Q2 		$4.59M Buy
+1,010,116
New +$5.43M 0.01% 1030

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Teachers Advisors's ARRY Position: Q1 2019 in Review

Teachers Advisors reduced its Array Biopharma Inc (ARRY) stake by 32% in Q1 2019, selling an estimated $7.09M and leaving 714,190 shares worth $17.4M. The position accounts for 0.02% of the portfolio, ranked #723.

Teachers Advisors first reported a position in ARRY in Q2 2013 and has held it in 24 quarters since. The position peaked at $24.5M in Q2 2018. 268 funds tracked by Wall St. Rank hold ARRY as of Q1 2019.

  • Teachers Advisors held 714,190 shares of Array Biopharma Inc worth $17.4M as of Q1 2019.
  • Teachers Advisors sold 340,694 Array Biopharma Inc shares in Q1 2019, an estimated $7.09M.
  • Array Biopharma Inc made up 0.02% of Teachers Advisors's portfolio in Q1 2019, its #723 holding.
  • Teachers Advisors first reported a position in Array Biopharma Inc in Q2 2013 and has held it in 24 quarters since.
  • Teachers Advisors's Array Biopharma Inc position peaked at $24.5M in Q2 2018.
  • 268 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.